Mitochondrial dysfunction in Parkinson's disease

Winklhofer, Konstanze F., Haass, Christian·2010·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Cited by (690)

Items 501–600 of 690

  1. The identification of dysfunctional crosstalk of pathways in Parkinson disease
    Hongyu Diao, Xinxing Li, Sheng Hu · 2012 · Gene
  2. Milk and Parkinson disease: Could galactose be the missing link
    Anna Rita Sarni, Luciana Baroni · 2018 · Mediterranean Journal of Nutrition and Metabolism
  3. Mitochondrial Dysfunction in Skeletal Muscle of Rotenone-Induced Rat Model of Parkinson’s Disease: SC-Nanophytosomes as Therapeutic Approach
    Daniela Mendes, Francisco Peixoto, Maria Manuel Oliveira, Paula B. Andrade, Romeu António Videira · 2023 · International Journal of Molecular Sciences
  4. Detecting mtDNA Effects with an Extended Pedigree Model: An Analysis of Statistical Power and Estimation Bias
    Xuanyu Lyu, Michael D. Hunter, Sybil Alexandra Burt, Rachel Good, Sarah L. Carroll, S. Mason Garrison · 2025 · Behavior Genetics
  5. Neurexin 2 p.G849D variant, implicated in Parkinson’s disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells
    Katelyn Cuttler, Dalene de Swardt, Lize Engelbrecht, Jurgen Kriel, Ruben E.A. Cloete, Soraya Bardien · 2022 · Journal of Neural Transmission
  6. Necrosis inhibitor-5 (NecroX-5), attenuates MPTP-induced motor deficits in a zebrafish model of Parkinson’s disease
    Juncheng Liu, Sushruta Koppula, Se Jong Huh, Pyo‐Jam Park, Chul Geun Kim, Chang‐Joong Lee, Chan-Gil Kim · 2015 · Genes & Genomics
  7. Bax inhibitor-1 suppresses early brain injury following experimental subarachnoid hemorrhage in rats
    Jiaxin Liu, Shuai Zhou, Yueting Zhang, Xiuying Li, Xiying Qian, Weihua Tao, Lide Jin, Jianhua Zhao · 2018 · International Journal of Molecular Medicine
  8. Sustained adenosine exposure causes endothelial mitochondrial dysfunction via equilibrative nucleoside transporters
    Junsuk Ko, Sharon Rounds, Qing Lü · 2020 · Pulmonary Circulation
  9. Mitochondria and Parkinson's Disease
    David K. Simon, Charleen T. Chu, Russell Howard Swerdlow · 2011 · Parkinson s Disease
  10. Tainted air: The link between pollution and Alzheimer's disease
    Emma Louise Walton · 2018 · Biomedical Journal
  11. Immunotherapies Targeting α -Synuclein in Parkinson Disease
    Fariha Jamal · 2020 · Federal Practitioner
  12. Association between dietary niacin intake and risk of Parkinson’s disease in US adults: cross-sectional analysis of survey data from NHANES 2005–2018
    Ling Zhang, Shaojie Yang, Xiaoyan Liu, Chunxia Wang, Ge Tan, Xueping Wang, Ling Liu · 2024 · Frontiers in Nutrition
  13. Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson’s Disease
    Federica Murgia, Luigi Atzori, Ezio Carboni, Maria Laura Santoru, Aran J. Hendren, Augusta Pisanu, Pierluigi Caboni, Laura Boi, Giuliana Fusco, Anna Rosa Carta · 2020 · International Journal of Molecular Sciences
  14. Human Platelet Mitochondrial Function Reflects Systemic Mitochondrial Alterations: A Protocol for Application in Field Studies
    Florian Hoppel, Luiz Felipe Garcia-Souza, Wilhelm Kantner-Rumplmair, Martin Burtscher, Erich Gnaiger, Dominik Hans Pesta, Elisa Calabria · 2021 · Cells
  15. Mitochondrial Dysfunction in Parkinson’s Disease
    Manisha Patel, Pallavi Bhuyan McElroy · 2017 · Royal Society of Chemistry eBooks
  16. miRNA family miR-29 inhibits PINK1-PRKN dependent mitophagy via ATG9A
    Briana N Markham, Chloe Ramnarine, Songeun Kim, William E. Grever, Alexandra I. Soto‐Beasley, Michael G. Heckman, Yingxue Ren, Andrew C. Osborne, Aditya Vijay Bhagwate, Yuanhang Liu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson’s Disease: A Review
    Alexandra Petiet · 2021 · Frontiers in Neuroscience
  18. Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
    Shahrooz Vahedi, Mehrnoosh Rajabian, Arman Misaghian, Daniel Grbec, Horst H. Simon, Kambiz N. Alavian · 2010 · Journal of Biomedical Science
  19. Neuroinflammation During Parkinson’s Disease: Key Cells and Molecules Involved in It
    Priyobrata Sinha, Nabanita Ghosh, Soham Mitra, Arindam Bhattacharyya · 2016 · Springer eBooks
  20. «One Small Step for Mouse»: High CO2 Inhalation as a New Therapeutic Strategy for Parkinson’s Disease
    Alexander D. Nadeev, Kristina A. Kritskaya, Evgeniya I. Fedotova, Alexey V. Berezhnov · 2022 · Biomedicines
  21. Microarrays, Enzymatic Assays, and MALDI-MS for Determining Specific Alterations to Mitochondrial Electron Transport Chain Activity, ROS Formation, and Lipid Composition in a Monkey Model of Parkinson’s Disease
    María Dolores García-Fernández, Ane Larrea, Roberto Fernández, Rafael Rodríguez‐Puertas, Egoitz Astigarraga, Iván Manuel, Gabriel Barreda‐Gómez · 2023 · International Journal of Molecular Sciences
  22. Kynurenine attenuates mitochondrial depolarization and neuronal cell death induced by rotenone exposure independently of AhR-mediated parkin induction in SH-SY5Y differentiated cells
    Rosario García-Aguilar, Arturo Ortega, Esther López‐Bayghen, Leticia Ramírez-Martínez, Ada G. Rodríguez-Campuzano, Fátima E. Murillo-González, Guillermo Elizondo, Libia Vega · 2023 · NeuroToxicology
  23. Pathogenesis of Parkinson's Disease
    Amitabh Gupta, Ted M. Dawson · 2009 · Blue books of neurology
  24. Neuroprotective and Antiapoptotic Effects of Allopregnanolone and Curcumin on Arsenic-Induced Toxicity in SH-SY5Y Dopaminergic Human Neuroblastoma Cells
    Hossein Khodadadi, Gila Pirzad Jahromi, G. Zaeinalifard, Mahdi Fasihi‐Ramandi, Mohammad Ali Esmaeili, Alireza Shahriary · 2020 · Neurophysiology
  25. Mitochondrial Ion Channels in Aging and Related Diseases
    Mohammad Ashrafuzzaman · 2022 · Current Aging Science
  26. Mitochondrial dysfunctions and neurodegenerative diseases: a mini-review
    Ratan Kumari, Nikhila Shekhar, Sakshi Tyagi, Ajit Kumar Thakur · 2021 · Journal of Analytical & Pharmaceutical Research
  27. Toxin-Mediated Complex I Inhibition and Parkinson’s Disease
    Briana R. De Miranda, Bennett Van Houten, Laurie H. Sanders · 2016 · Springer eBooks
  28. Pluripotent Stem Cells for Uncovering the Role of Mitochondria in Human Brain Function and Dysfunction
    Annika Zink, Josef Priller, Alessandro Prigione · 2018 · Journal of Molecular Biology
  29. Presence of ES1 homolog in the mitochondrial intermembrane space of porcine retinal cells
    Shinto Utsumi, Kimitoshi Sakamoto, Tetsuro Yamashita, Hiroshi Tomita, Eriko Sugano, Kinji Ishida, Eri Ishiyama, Taku Ozaki · 2020 · Biochemical and Biophysical Research Communications
  30. Bioinformatics Approach to Identify Diseasome and Co-morbidities Effect of Mitochondrial Dysfunctions on the Progression of Neurological Disorders
    Md. Shahriare Satu, Koushik Chandra Howlader, Tajim Md. Niamat Ullah Akhund, Fazlul Huq, Julian M.W. Quinn, Mohammad Ali Moni · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits
    Wouter Peelaerts, Liza Bergkvist, Sonia George, Michaela Johnson, Lindsay K. Meyerdirk, Emily Ku, Jennifer A. Steiner, Zachary Madaj, Jiyan Ma, Katelyn Becker et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Neurotransmitter accumulation and Parkinson's disease‐like phenotype caused by anion channelrhodopsin opto‐controlled astrocytic mitochondrial depolarization in substantia nigra pars compacta
    Sen‐Miao Li, Dian‐Dian Wang, Dan-Hua Liu, Xiao‐Yan Meng, Zhizhong Wang, Xitong Guo, Qian Liu, Peipei Liu, Shuang Li, Songwei Wang et al. · 2024 · MedComm
  33. EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART
    Frank Faltraco, Simone Lista, Francesco Garaci, Heather Hampel · 2012 · Cineca Institutional Research Information System (Tor Vergata University)
  34. Mathematical model to study the effect of mitochondria on Ca2+ diffusion in Parkinsonic nerve cells
    Hardik Joshi, Brajesh Kumar Jha, Devanshi D. Dave · 2018 · AIP conference proceedings
  35. PREDICTION OF ANTI-PARKINSON POTENTIAL OF PHYTOCONSTITUENTS USING PREDICTION OF ACTIVITY SPECTRA OF SUBSTANCES SOFTWARE
    Rajan Kumar, Rakesh Kumar, Abhinav Anand, Neha Sharma, Navneet Khurana · 2018 · Asian Journal of Pharmaceutical and Clinical Research
  36. Aspalathin and linearthin from Aspalathus linearis (Rooibos) protect SH-SY5Y cells from MPP+-induced neuronal toxicity
    Sylvester Ifeanyi Omoruyi, Akeem Omolaja Akinfenwa, Okobi Eko Ekpo, Ahmed Abdullah Hussein · 2023 · South African Journal of Botany
  37. The Effect of Taheri Consciousness Fields on the ATP Production in HEK-293 Cell Line by Measuring Luciferase Activity
    Mohammad Ali Taheri, Sara Torabi, Farid Semsarha · 2022 · The Scientific Journal of Cosmointel
  38. Trans-zeatin and its derivatives: Cytokinins present in various TCM preparations as promising candidate moclecules for the management of Alzheimer's and Parkinson's disease
    Adarsh Kesharwani, Siva Prasad Panda · 2024 · Pharmacological Research - Modern Chinese Medicine
  39. Functional Role of Parkin against Oxidative Stress in Neural Cells
    Minyoung Hwang, Ja-myong Lee, Younghwa Kim, Dongho Geum · 2014 · Endocrinology and Metabolism
  40. AZT Treatment Increases mtDNA Mutations in HepG2 and CCD-1112Sk Cells
    Adam E. Osborne John E. Rice · 2013 · Journal of AIDS & Clinical Research
  41. The Ageing Brain, Mitochondria and Neurodegeneration
    Gavin Hudson · 2016 · Springer eBooks
  42. The Effect of Exercise on Parkinson's Disease
    Zeinab Rezaee, Mohammad Marandi, hojjataalah alaei, Fahimeh Esfarjani · 2020 · The Neuroscience Journal of Shefaye Khatam
  43. Multifaceted Therapy of Nanocatalysts in Neurological Diseases
    Heping Wang, Xi Chen, Mingxing Mao, Xue Xue · 2021 · Journal of Biomedical Nanotechnology
  44. Mutational screening of the Mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease
    Elena Sánchez-Ferrero, Eliécer Coto, Marta Blázquez Estrada, René Ribacoba, Luis M. Guisasola, Carlos Salvador, Victoria Álvarez · 2008 · Parkinsonism & Related Disorders
  45. Comparative functional genomic analysis of Alzheimer’s affected and naturally aging brains
    Yi-Shian Peng, Chia-Wei Tang, Yi-Yun Peng, Hung Chang, Chien‐Lung Chen, Shulin Guo, Li-Ching Wu, Min-Chang Huang, Hoong-Chien Lee · 2020 · PeerJ
  46. Stress response in the cyanobacterium Synechocystis sp. PCC 6803
    Hélder Miranda · 2011 · DiVA at Umeå University (Umeå University)
  47. The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors
    Elisabet Jakova, Omozojie P. Aigbogun, Mohamed Taha Moutaoufik, Kevin J H Allen, Omer Munir, Devin Brown, Changiz Taghibiglou, Mohan Babu, Christopher P. Phenix, Ed S. Krol et al. · 2024 · International Journal of Molecular Sciences
  48. Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine
    Qiao-Li Wang, Xuan Gu, Le Yang, Yan Jiang, Jiao Zhang, Jinting He · 2024 · Frontiers in Aging Neuroscience
  49. A non-purine inhibitor of xanthine oxidoreductase mitigates adenosine triphosphate degradation under hypoxic conditions in mouse brain
    Nana Sato, Teruo Kusano, Koji Nagata, Ken Okamoto · 2025 · Brain Research
  50. Brain Ascorbate: Protective, Yet Permissive for Redox Signaling
    Margaret E. Rice · 2011 · Advances in neurobiology
  51. The Energy Crisis in Parkinson’s Disease: A Therapeutic Target
    Mhamad Abou-Hamdan, Emilie Cornille, Michel Khrestchatisky, M B A Barros de, Bouchra Gharib · 2011 · InTech eBooks
  52. Computational Prediction of a Putative Binding Site on Drp1: Implications for Antiparkinsonian Therapy
    Hanumanthappa Pradeep, Golgodu Krishnamurthy Rajanikant · 2014 · Journal of Chemical Information and Modeling
  53. Parkinson’s Disease and Aging
    Julie Kay Andersen, Shankar J. Chinta · 2015 · Springer eBooks
  54. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein
    Ria Biswas, Angshuman Bagchi · 2017 · Gene
  55. Gene network analysis to determine the effect of hypoxia-associated genes on brain damages and tumorigenesis using an avian model
    Hamed Kharrati-Koopaee, Esmaeil Ebrahimie, Mohammad Dadpasand, Ali Niazi‎, Rugang Tian, Ali Esmailizadeh · 2021 · Journal of Genetic Engineering and Biotechnology
  56. Mitochondrial respiratory chain enzyme activities, mtDNA variants and gene expression levels in idiopathic parkinson’s disease
    Ayşe Ercan, Gulnihal Kulaksiz-Erkmen, Özlem Dalmızrak, Meltem Müftüoğlu, İ. Hamdi Öğüş, Leyla Y. Cavdar, Levent Ertuğrul İnan, Nesrin Kartal Özer · 2009 · Turkish Journal of Biochemistry
  57. Broader implications: biological and clinical significance of microtubule acetylation
    Thomas J. Kelley, Sharon M. Rymut · 2015 · Cell Health and Cytoskeleton
  58. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson’s disorder
    Hongxia Zhao, Qinghua Zhang, Huifang Chen, Md Rezanur Rahman, Hossain Md. Faruquee · 2021 · Saudi Journal of Biological Sciences
  59. Mitochondrial DNA Mutations and Their Effects on Complex I Biogenesis: Implications for Metabolic Disease
    Matthew McKenzie · 2012 · Humana Press eBooks
  60. Protective effects of pyrroloquinoline quinone in CNS disorders
    Sara Aboulhassane, Vishal Sangha, Reina Bendayan · 2025 · The Journal of Nutritional Biochemistry
  61. Nanotechnology-based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders
    Dnyandev G. Gadhave, Varsha V. Kale, Aishwarya P. Kade, Onkar R. Jadhav, Vrashabh V. Sugandhi, Vishal Bharat Babar, Shubham V. Khot, Chandrakant Kokare, Keshav Raj Paudel · 2026 · Ageing Research Reviews
  62. The Role of Polyphenols on Cognitive Function and Dementia Through Gut–Microbiota–Brain Axis Modulation: A Narrative Review
    Oualid Sbai, Aishwarya Chaure, Lorena Perrone, Patrick Poucheret · 2026 · Nutrients
  63. Neuronal degeneration, mitochondrial dysfunction, and disturbance of movements induced by rotenone in the ascidian Styela plicata
    Nathany da Silva Nogueira, Taynan Motta Portal, Thuany da Silva Nogueira, A. Miranda, Eldo Campos, Cíntia Monteiro de Barros · 2025 · NeuroToxicology
  64. Genetics of Parkinson’s Disease: The Role of Copy Number Variations
    Valentina La Cognata, Velia D’Agata, Francesca Cavalcanti, Sebastiano Cavallaro · 2016 · InTech eBooks
  65. Measurement of Mitochondrial Toxicity Parameters in Embryonic Hippocampus
    Ahmad Salimi, Jalal Pourahmad · 2018 · Methods in molecular biology
  66. Pros and Cons of Cannabinoids as a Potential Therapeutic Target for Treating Parkinson's Disease
    Mahesh Pattabhiramaiah, Shanthala Mallikarjunaiah, Baishali Bedi Sarma · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  67. Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes
    Tereza Bartošová, Jiří Klempíř, Hana Hansíková · 2023 · Antioxidants
  68. Peptide Activator Stabilizes DJ-1 Structure and Enhances Its Activity
    Jing-Yuan Shih, Yuan‐Hao Hsu · 2024 · International Journal of Molecular Sciences
  69. Animal Model for Leigh Syndrome
    Sara El-Desouky, Yasmeen M. Taalab, Mohamed El‐Gamal, Wael M.Y. Mohamed, Mohamed Salama · 2019 · Methods in molecular biology
  70. Dopamine modulation affects the performance of parkinsonian patients in a precision motor task measured by an antropomorphic device
    Cristina Nombela, Juan Luis Pedreño-Molina, Francisco Ros‐Bernal, Javier Molina-Vilaplana, Emiliano Fdez-Villalba, JUAN LÓPEZ-CORONADO, María Trinidad Herrero · 2012 · Human Movement Science
  71. The human extended mitochondrial metabolic network: New hubs from lipids
    Luigi Leonardo Palese, Fabrizio Bossis · 2012 · Biosystems
  72. Molecular Process and Physiological Significance of Mitophagy
    Ke Wang, Daniel J. Klionsky · 2014 · Elsevier eBooks
  73. Insights into various dysfunctions in Parkinson’s disease: a survey
    Shri Dhar, Jyotsna Singh, Phool Singh · 2016 · CSI Transactions on ICT
  74. Organ Damage in HIV-Positive Patients with High Blood Pressure
    Giuseppe Vittorio De Socio · 2013 · Journal of AIDS & Clinical Research
  75. Agrochemicals-Induced Dopaminergic Neurotoxicity: Role of Mitochondria-Mediated Oxidative Stress and Protein Clearance Mechanisms
    Neeraj Singh, Vivek Lawana, Niranjana Krishnan, Sri Harsha Kanuri, Huajun Jin, Vellareddy Anantharam, Anumantha G. Kanthasamy, Arthi Kanthasamy · 2015 · Current topics in neurotoxicity
  76. Phytotherapeutic targeting of the mitochondria in neurodegenerative disorders
    Priyanka Sarkar, Ashish A. Kumar, Partha Sarathi Behera, Kavitha Thirumurugan · 2023 · Advances in protein chemistry and structural biology
  77. Dopamine Toxicity Induces ROS-Dependent Death of Murine Neuroblastoma Cells: Impact on the Interactions of Cofilin With UCHL1 and MMP9
    Tapasi Roy, Rachana Banerjee, Abhishek Chatterjee, Snehasikta Swarnakar · 2025 · Neurochemical Research
  78. Spatial transcriptomics and multi-omics approach to decipher age-related tissue microenvironments and therapeutics in neurodegeneration and aging
    Apurva Lakra, Nishita Singh, Shrutikirti Vashishth, Rashmi K. Ambasta, Pravir Kumar · 2026 · Ageing Research Reviews
  79. The Role of Mitochondrial Oxidative Stress in Retinal Dysfunction
    Stuart Gordon Jarrett, Alfred S. Lewin, Michael E. Boulton · 2012 · Humana Press eBooks
  80. Oxidative Stress and Neurodegeneration
    Newman Osafo, David Darko Obiri, Kwabena Owusu Danquah, Kofi Oduro Yeboah, Aaron Opoku Antwi, Mahmood Brobbey Oppong · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  81. Effect of low-level laser therapy on neurorehabilitation: A narrative review
    Milad Soluki, Arash Abdolmaleki, Fariba Mahmoudi, Asadollah Asadi, M. Moazedi · 2021 · Journal of Laser Applications
  82. Parkinson’s Disease
    Hsin Fen Chien, Egberto Reis Barbosa, Carolina de Oliveira Souza, Alice Estevo Dias, Juliana Conti · 2016 · Springer eBooks
  83. Role of mitochondria in brain functions and related disorders
    Monu Yadav, Mini Dahiya, Jyoti Dagar, Narender Singh, Nidhi Sharma, Nitin Rawat, Pratibha Dhakla, Neha Minocha, Anil Kumar · 2022 · Exploration of Medicine
  84. Dopamine Protects Neurons against Glutamate-Induced Excitotoxicity
    Evgeniya I. Fedotova, Andrey Y. Abramov, Alexey V. Berezhnov · 2023 · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology
  85. Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's Disease
    Fulya Akçimen, Vesna Marija van Midden, S. Can Akerman, Mary B. Makarious, Global Parkinson's Genetics Program, Jeffrey D. Rothstein, Zih‐Hua Fang, Sara Bandrés‐Ciga · 2024 · Movement Disorders
  86. GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease
    Yue Wang, Jiang Fang, Qiang Yuan, Jian Ling Yu, Jin Hu · 2025 · Journal of Inflammation Research
  87. In vitro Neuroprotective Effects of Seven Natural Products Against Rotenone-induced Toxicity in a SH-SY5Y Neuroblastoma Cells Model for Parkinson's Disease
    Nuria de Pedro, Bastien Cautain, Juan Cantizani, Lorena Rodríguez, Francisca Vicente, RatnaTualsi, Sundar Rao Koyyalamudi · 2016 · Pharmacologia
  88. Cell energy metabolism : a constrained ensemble Kalman filter
    G. Goffaux, Michel Perrier, Mathieu Cloutier · 2011 · IFAC Proceedings Volumes
  89. Oxidative stress modulation in neurodegenerative diseases
    Cecilia Carlesi, Elena Caldarazzo Ienco, Selina Piazza, Annalisa Lo Gerfo, R. Alessi, Livia Pasquali, Gabriele Siciliano · 2011 · Mediterranean Journal of Nutrition and Metabolism
  90. Papel de la función mitocondrial en las enfermedades neurodegenerativas
    Mayela Rodríguez‐Violante, Amin Cervantes‐Arriaga, Steven Vargas‐Cañas, Teresa Corona · 2010 · Archivos de Neurociencias
  91. Optical Approaches to Studying the Basal Ganglia
    Joshua L. Plotkin, Jaime N. Guzmán, Nicholas Schwarz, Geraldine J. Kress, David L. Wokosin, Dalton James Surmeier · 2011 · Neuromethods
  92. Neuroprotective Properties of Glutamate Metabotropic Glutamate Receptors in Parkinson’s Disease and Other Brain Disorders
    Gunasingh Jeyaraj Masilamoni, Yoland Smith · 2017 · The Receptors
  93. Human induced pluripotent stem cell-derived neuronal progenitors are a suitable and effective drug discovery model for neurological mtDNA disorders
    Jonas Walter, Sarah Nickels, Jens Christian Schwamborn · 2017 · Stem Cell Investigation
  94. Changes in intrinsic excitability of hippocampal pyramidal cells in Parkinson’s disease model
    A Y Wu · 2024 · Theoretical and Natural Science
  95. Metabolic Imbalance Associated Mitophagy in Tumor Cells: Genesis and Implications
    Madhuri Chaurasia, Shashank Misra, Anant Narayan Bhatt, Asmita Das, Bilikere Srinivasa Rao Dwarakanath, Kulbhushan Sharma · 2015 · Journal of cancer research updates
  96. Mitochondrial Impairment Mechanism in D-galactose-induced Senescence in Experimental Fibroblast Cell Model
    Wei Ye, Jianming Cao, Xiao-Jun Tang, Chu Liu, Dongjie Hao, Jing Jin, Jianxin Lü · 2016 · International Conference on Biological Sciences and Technology (BST)
  97. Neurological Diagnoses Identify Molecular Processes
    John Hardy · 2010 · Archives of Neurology
  98. Effects of curcumin, quercetin, and their combinationson neurodegeneration and motor impairment in rotenone-induced Parkinson's disease in rats
    Mehak Lard, Shweta deol, Meenakshi Dhanawat, Dinesh Kumar Mehta, Rina Das, Sumeet Gupta, Mohamed Aly Morsy, Anroop Balachandran Nair, Asmaa Ibrahim Matouk, Nidhi Gupta · 2022 · Research Square
  99. Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
    Marcos Antonio Formiga-Jr, Juliana Camacho-Pereira · 2022 · Journal of Visualized Experiments
  100. Cogs in the autophagic machine—equipped to combat dementia-prone neurodegenerative diseases
    Sholto de Wet, Rensu P. Theart, Ben Loos · 2023 · Frontiers in Molecular Neuroscience